Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Dina V. Diaz"'
Autor:
David Price, Maarten J. H. I. Beekman, Walter Javier Mattarucco, Rocio Martina Barriga-Acevedo, Hao-Chien Wang, Dina V. Diaz, Adel Khattab, Manuel Pacheco Gallego, Ashraf Al Zaabi, Hisham Farouk, Darush Attar-Zadeh
Publikováno v:
npj Primary Care Respiratory Medicine, Vol 34, Iss 1, Pp 1-10 (2024)
Abstract This post-hoc analysis of the SABINA III study evaluated the association of short-acting β2-agonist (SABA) prescriptions and self-reported over-the-counter (OTC) SABA purchase in the previous 12 months with asthma-related outcomes using mul
Externí odkaz:
https://doaj.org/article/4984de67e7944ce78fa9ef64795d2b8b
Autor:
Hao-Chien Wang, MD PhD, Susanthy Djajalaksana, MD, Latha Sharma, MD, Theerakorn Theerakittikul, MD, Hui Fang Lim, MBBS, Kwang Ha Yoo, MD, Andrea Ban Yu-Lin, MMED, Dina V. Diaz, MD, Lala Yang, Master, Maarten J.H.I. Beekman, MD
Publikováno v:
World Allergy Organization Journal, Vol 16, Iss 10, Pp 100823- (2023)
Background: The extent of short-acting Beta-2-agonist (β2-agonist) (SABA) use across Asian countries is not well documented. As part of the SABA use IN Asthma (SABINA) III study, we assessed SABA prescriptions and clinical outcomes in patients with
Externí odkaz:
https://doaj.org/article/51ae20e04399444f938423b738c2d388
Autor:
Alev Gürgün, Peter Frith, Konstantinos Kostikas, Arthur Backer, Anna Marie Hamann, Dina V Diaz, Virginia Pilipovic, Samiha Ashmawi, Flash Investigators, Sashka Hristoskova, Petter Olsson, Srikanth Krishnamurthy
Publikováno v:
Respirology (Carlton, Vic.). 23(12)
Background and objective Combination long-acting β2 -agonist/long-acting muscarinic antagonist (LABA/LAMA) has demonstrated superior clinical outcomes over LABA/inhaled corticosteroid (ICS) in chronic obstructive pulmonary disease (COPD) patients; h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04a70f15aabd3987da7d27195e231dd8
https://pubmed.ncbi.nlm.nih.gov/30315609
https://pubmed.ncbi.nlm.nih.gov/30315609